Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China
Cancer Medicine · 2024-06 · 13 (11)
DOI: 10.1002/cam4.7316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 03.06.2024. Verfasst von Changchang Dun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Medicine, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical Coll…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Papillomavirus Infections, Triage. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
Objective
To assess the clinical values of extended human papillomavirus (HPV) genotyping in triage of high‐risk HPV‐positive women, focusing on the trade‐off between cervical precancer detections and colposcopy referrals.
Methods
A bivariate random‐effects model was used to estimate the diagnostic accuracy of primary HPV screening with following triage strategies to detect cervical precancers: (i) partial genotyping for HPV16/18 combined with cytological testing at atypical squamous cells of undetermined significance threshold (used as the comparator), (ii) genotyping for HPV16/18/58/52, (iii) genotyping for HPV16/18/58/52/33, (iv) genotyping for HPV16/18/58/33/31, (v) genotyping for HPV16/18/58/52/33/31, and (vi) genotyping for HPV16/18/58/52/33/31/39/51. Internal risk benchmarks for clinical management were used to evaluate the risk stratification of each triage strategy.
Results
A total of 16,982 women (mean age 46.1 years, range 17–69) were included in this analysis. For CIN3+ detection, triage with HPV16/18/58/33/31 genotyping achieved lower positivity (6.85% vs. 7.35%, p = 0.001), while maintaining similar sensitivity (91.35% vs. 96.42%, p = 0.32) and specificity (94.09% vs. 93.67%, p = 0.56) compared with the comparator strategy. Similar patterns were observed for CIN2+ detection. Women with a positive HPV16/18/58/33/31 genotyping test had high enough risk for CIN3+ for colposcopy referral, while the risk for women with a negative test was below the 1‐year return decision threshold according to internal benchmarks.
Conclusions
Our findings suggested extended HPV genotyping is of potential to be used as a triage technique integrated into HPV‐based cervical cancer screening, leading to reduced need for colposcopy referral while maintaining similar disease detection and efficient risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population Medicine, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Unit of Cancer Epidemiology, Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium.
ORCID-Profile: Fanghui Zhao
Förderung
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Dun, C., Yuan, M., Zhao, X., Hu, S., Arbyn, M., & Zhao, F. (2024). Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China. Cancer Medicine, 13(11). https://doi.org/10.1002/cam4.7316
Vancouver
Dun C, Yuan M, Zhao X, Hu S, Arbyn M, Zhao F. Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China. Cancer Medicine. 2024;13(11). doi:10.1002/cam4.7316
BibTeX
@article{Dun2024,
author = {Dun, Changchang and Yuan, Meiwen and Zhao, Xuelian and Hu, Shangying and Arbyn, Marc and Zhao, Fanghui},
title = {Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population‐based cervical cancer screening studies from China},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {11},
doi = {10.1002/cam4.7316}
}
EUVIMED